SymBio Pharmaceuticals Ltd
TSE:4582
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
S
|
SymBio Pharmaceuticals Ltd
TSE:4582
|
JP |
|
Tsubaki Nakashima Co Ltd
TSE:6464
|
JP |
|
Biomerieux SA
PAR:BIM
|
FR |
|
C
|
Carter's Inc
F:HCH
|
US |
Intrinsic Value
Is SymBio Pharmaceuticals Ltd undervalued or overvalued?
See the intrinsic value estimate for SymBio Pharmaceuticals Ltd and find out whether today’s valuation is cheap or expensive by its own historical standards.
Do our valuations actually work? See backtest results .
SymBio Pharmaceuticals Ltd looks undervalued.
But is it cheap by its own standards?
See how today’s valuation compares with SymBio Pharmaceuticals Ltd’s past valuations and how the stock performed after similar periods.
Fundamental Analysis
What SymBio Pharmaceuticals Does
SymBio Pharmaceuticals is a Japanese specialty drug company focused on cancer and blood disorders. It does not run a broad drug pipeline like a large pharmaceutical firm; instead, it in-licenses medicines from other developers, handles local development and approvals, and then sells those drugs in its target markets. Its main products are oncology treatments, especially medicines used in hospitals by doctors treating patients with hard-to-treat cancers and hematologic diseases.
- Headquarters
- Japan JP
- Employees
- 91
- IPO date
- Oct 20, 2011
Revenue & Expenses Breakdown
SymBio Pharmaceuticals Ltd
Earnings Waterfall
SymBio Pharmaceuticals Ltd
The intrinsic value for SymBio Pharmaceuticals Ltd (4582) under the Base Case is hidden JPY.
Compared with the current market price of 47 JPY, the stock appears hidden.